Wordt geladen...
A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects
PURPOSE: Valsartan, an angiotensin-receptor blocker, and rosuvastatin, a competitive inhibitor of the 3-hydroxy-3-methylglutaryl coenzyme A reductase, are frequently coadministered to treat patients with hypertension and dyslipidemia. The study reported here sought to evaluate the pharmacokinetic an...
Bewaard in:
| Gepubliceerd in: | Drug Des Devel Ther |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354399/ https://ncbi.nlm.nih.gov/pubmed/25767372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S76942 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|